Guidelines for Mosquito Control in Built-Up Areas in Europe

Published by Frederik Seelig on Oct 15, 2024

Disclaimer

Platform contribution 

EMCA would like to acknowledge the MAGIC Evidence Ecosystem Foundation for their support in the consolidation of the Guidelines on the MAGICapp platform.

 

Sponsors

This investigation/activity received financial support from TDR, the Special Programme for Research and Training in Tropical Diseases co-sponsored by UNICEF, UNDP, the World Bank and WHO. TDR is able to conduct its work thanks to the commitment and support from a variety of funders. These include our long-term core contributors from national governments and international institutions, as well as designated funding for specific projects within our current priorities. For the full list of TDR donors, please visit their website at: https://www.who.int/tdr/about/funding/en/

 

Contact

Abstract

This document is a PDF generated from the EMCA guidelines for mosquito control hosted on the MAGICapp online platform: https://app.magicapp.org/#/guideline/jDRvgn. Each time the content of the platform is updated, a new PDF version of the Guidelines will be downloadable on the EMCA website to facilitate access where the Internet is not available. Users should note the downloaded PDFs of the Guidelines may be outdated and not contain the latest recommendations. Please consult with the website for the most up-to-date version of the Guidelines.

Language

en-gb

PICOS

PICO 10.1

Population
human populations in built-up European areas
Intervention
larval source reduction through environmental management (catch basin modification)
Comparator
no control action
Outcomes

PICO 10.2

Population
human populations in built-up European areas
Intervention
physical control by UNFO-PLS
Comparator
no such control action
Outcomes

PICO 10.3

Population
human populations in built-up European areas
Intervention
physical control by silicone-based products
Comparator
no such control action
Outcomes

PICO 10.4

Population
human populations in built-up European areas
Intervention
biological control by predators (copepods)
Comparator
no such control action
Outcomes

PICO 10.5

Population
human populations in built-up European areas
Intervention
biological control by microbiological agents (Bti)
Comparator
no such control action
Outcomes

PICO 10.6

Population
human populations in built-up European areas
Intervention
chemical control by insect growth regulators (pyriproxyfen)
Comparator
no such control action
Outcomes

PICO 10.7

Population
human populations in built-up European areas
Intervention
chemical control by insect growth regulators (diflubenzuron)
Comparator
no such control action
Outcomes

PICO 10.8

Population
human populations in built-up European areas
Intervention
Autodissemination of insect growth regulators
Comparator
no such control
Outcomes

PICO 20.1

Population
human populations in built-up European areas
Intervention
mass trapping
Comparator
no such control action
Outcomes

PICO 20.2

Population
human populations in built-up European areas
Intervention
Sterile Insect Technique (SIT) and larviciding (Bti)
Comparator
larviciding (Bti)
Outcomes

PICO 20.3

Population
human populations in built-up European areas
Intervention
chemical control by adulticides (ultra-low volume space treatments, cold-fogging)
Comparator
no such control action
Outcomes

PICO 20.4

Population
human populations in built-up European areas
Intervention
chemical control by adulticides (ultra-low volume space treatments, thermal fogging)
Comparator
no such control action
Outcomes

PICO 20.5

Population
human populations in built-up European areas
Intervention
chemical control by adulticiding (pyrethroids by outdoor residual spraying)
Comparator
no such control action
Outcomes

PICO 20.6

Population
human populations in built-up European areas
Intervention
Sterile insect technique (SIT) (irradiation-induced)
Comparator
No intervention
Outcomes

PICO 20.7

Population
human populations in built-up European areas
Intervention
Wolbachia Incompatible Insect Technique (IIT)
Comparator
No intervention
Outcomes

PICO 30.1

Population
human populations in built-up European areas
Intervention
chemical control by insect growth regulators (pyriproxyfen) and adulticiding by permethrin, B. bassiana or Spinosad
Comparator
no such control action
Outcomes

PICO 30.2

Population
human populations in built-up European areas
Intervention
Sterile insect technique (SIT) (irradiation-induced) and source reduction
Comparator
Source Reduction
Outcomes

PICO 30.3

Population
human populations in built-up European areas
Intervention
Source reduction, larviciding and adulticiding in sensitive areas
Comparator
no control action
Outcomes

PICO 30.4

Population
Aedes albopictus mosquitoes
Intervention
Source reduction, biological larviciding (Bti), and SIT
Comparator
Source reduction, Biological larviciding (Bti)
Outcomes

PICO 30.5

Population
human populations in built-up European areas
Intervention
Source reduction, larvicide treatment, rubbish removal, and adulticiding in recreation parks
Comparator
No intervention
Outcomes

PICO 30.6

Population
human populations in built-up European areas
Intervention
Chemical control by insect growth regulators (diflubenzuron) and adulticides (pyrethroids)
Comparator
No control action
Outcomes

PICO 30.7

Population
Human population in built-up areas in Europe
Intervention
Larviciding in public road drains + door-to-door strategy (DtoD): monthly inspections of private properties + larval treatment of permanent breeding sites + removal/inactivation of occasional breeding sites + predatory copepods in large permanent containers + direct information to residents + communication campaigns
Comparator
Larviciding in public road drains
Outcomes

PICO 30.8

Population
human populations in built-up European areas
Intervention
Source reduction, biological larviciding (Bti) and public education campaign
Comparator
No interventions
Outcomes

PICO 30.9

Population
human populations in built-up European areas
Intervention
IVM by larviciding (IGRs and Bti) and information campaign
Comparator
no IVM
Outcomes